BML-286 is a WNT pathway modulator with potential anticancer activity, inducing beta-catenin- and TCF-dependent transcriptional activity, and can be used in the study of degenerative diseases, intestinal, breast, bladder, gastric, melanoma, leukemia, hepatocellular carcinoma and nephroblastoma.
Molecular Weight:
374.39
Purity:
98.44%
CAS Number:
[294891-81-9]
Formula:
C22H18N2O4
Target:
Wnt/beta-catenin
T200419
* VAT and and shipping costs not included. Errors and price changes excepted